Rare Blue Lobster Caught Off New Hampshire Coast : NPR
So what do blue lobsters have to do with underwriting?

Rare Blue Lobster Caught Off New Hampshire Coast : NPR
So what do blue lobsters have to do with underwriting?

Child Health – ADHD Drug Abuse Prevalent Among American Teens | Health News
When researchers evaluated an eight-year period of data from the American Association of Poison Control Centers, they found that calls involving 13- to 19-year-olds related to teen abuse of stimulants, including ADHD drugs, rose from 330 in 1998 to 581 in 2005—a 76 percent increase. Overall, 42 percent of teens involved had moderate to severe side effects and most ended up receiving treatment in emergency rooms. Four of the cases evaluated resulted in death. Study author, Dr. Randall Bond, medical director of Cincinnati Children’s Hospital Medical Center’s Drug and Poison Information Center, says that because many cases don’t result in calls to poison control centers, the true number of teen abusers who have harmful side effects is likely much higher.

2 Cheyenne Middle School students in Edmond Memorial Hospital after eating weed | NewsOK.com
I was surprised to read this story but less surprised at what teens will put in their bodies.

I’m clear, you’re clear, everybody’s clear.
But for competitive reasons… Extra Super Best Premier Preferred!
Medical News: Sleep Apnea Carries Risk of Death – in Pulmonary, Sleep Disorders from MedPage Today
Participants with severe sleep apnea were 46% more likely to die (95% CI 1.14 to 1.86), according to the report published online in the open access journal PLoS Medicine.

EMSI in Waco, TX is looking for remote fee based underwriters. These positions are remote but apparently part-time only.
Addendum March 2011
Looking for Underwriting Consultants with Health/DI and Reinsurance disciplines. Remote positions-flexible schedules. Call or email Traci Davis VP Underwriting Operations.
I suppose Saphris sounds better than asenapine.
FDA approval was based on data from more than 3,000 patients showing statistically significant efficacy versus placebo in acute schizophrenia trials and statistically significant reduction of bipolar mania symptoms versus placebo.

You must be logged in to post a comment.